In today’s trading landscape, several stocks are capturing investors’ attention. Tata Motors has revealed its intention to appoint Deloitte Haskins & Sells LLP as its statutory auditors starting from the 2027-28 financial year, pending the fulfillment of regulatory requirements. Meanwhile, IndusInd Bank continues to navigate challenges related to accounting discrepancies, prompting the Reserve Bank of India (RBI) to reassure stakeholders about the institution’s financial stability. Let’s dive deeper into the key updates that could shape market dynamics.
Tata Motors Revamps Audit Strategy
Tata Motors is set to transition to Deloitte Haskins & Sells LLP as its auditor from the upcoming financial year of 2027-28. This change comes as the company seeks to enhance its financial oversight, while current auditors, BSR & Co LLP, will remain in place until the conclusion of the 2026-27 financial year.
IndusInd Bank Faces Scrutiny
IndusInd Bank has been under the microscope due to accounting issues in its derivatives portfolio, which has resulted in a reported 2.35% drop in net worth as of December 2024. However, the RBI has stepped in, reminding depositors that the bank is well-capitalized and on solid financial footing. To address the situation, the bank has engaged an external audit team to assess the impacts thoroughly.
- HDFC Mutual Fund has increased its stake in IndusInd Bank by 0.20%, raising its total ownership to 5.02%.
- The RBI has also granted CEO Sumant Kathpalia a one-year extension amidst the ongoing financial hurdles.
Dr. Reddy’s Initiates Recall
In a significant move, Dr. Reddy’s Laboratories has announced a voluntary recall of its Levetiracetam 0.75% sodium chloride injection in the U.S. due to incorrect labeling on the product’s infusion bags.
Zydus Lifesciences Secures FDA Approval
Zydus Lifesciences has garnered final approval from the U.S. Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets in both 75 mg and 100 mg formulations. This milestone marks a significant advancement for the company in the pharmaceutical sector.
KEC International Expands Order Book
KEC International, a leading player in infrastructure and engineering, has successfully secured new contracts worth ₹1,445 crore in the Transmission & Distribution (T&D) sector. This brings the company’s year-to-date order intake to ₹20,600 crore, reflecting an impressive 80% increase compared to the previous year.
Voltas Appoints New CFO
The Board of Voltas has appointed K.V. Sridhar as the new Chief Financial Officer (CFO), effective April 1, 2025. He will take over from Jitender Pal Verma, who is retiring. Additionally, the Board has approved the transfer of its overseas branches in Dubai and Abu Dhabi to its subsidiary, Universal MEP Contracting LLC, for a consideration between ₹45 crore and ₹70 crore.
KPIT Technologies Welcomes New Investor
KPIT Technologies is set to welcome Qualcomm Ventures LLC as a new stakeholder in Qorix GmbH, joining existing partners KPIT Technologies and ZF Group with a potential investment of up to €10 million.
Tata Consultancy Services Leadership Change
Tata Consultancy Services (TCS) has appointed Sudeep Kunnumal as the Chief Human Resources Officer (CHRO) Designate, effective March 14, 2025. He will succeed Milind Lakkad upon his retirement, ensuring a smooth transition in leadership.
Tejas Networks Receives Government Incentive
Tejas Networks has been awarded an incentive of ₹123.45 crore for the fiscal year 2023-24 under the government’s Production-Linked Incentive (PLI) scheme, aimed at boosting the telecom and networking sectors.
Galaxy Surfactants Declares Interim Dividend
Galaxy Surfactants, a prominent manufacturer in the specialty chemicals sector, has declared an interim dividend of ₹18 per equity share, which represents 180% of its face value. Shareholders should note that the record date for this dividend is March 20, 2025, with payments expected within 30 days of the announcement.
These developments highlight the dynamic nature of the market, providing investors with ample opportunities and considerations as they make informed decisions.